ANGIOCRINE BIOSCIENCE, INC.

Profile

Company Names

ANGIOCRINE BIOSCIENCE, INC.

Addresses

11585 SORRENTO VALLEY RD, STE 109, SAN DIEGO, CA 92121

11575 SORRENTO VALLEY RD, STE 217, SAN DIEGO, CA 92121

1300 YORK AVENUE, NEW YORK, NY 10065

Phone Numbers

858-436-8047
(877) 784-8496
(530) 745-9560

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY

Year Incorporated:

2012

State Incorporated:

DELAWARE

Total Amount Raised:

$64,221,795.00

Number of Funding Rounds:

3
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
3
2025-08-21 
$2,100,000.00 
$3,000,000.00 
$900,000.00 
Equity 
2
2021-10-01 
$58,121,796.00 
$99,372,730.00 
$41,250,934.00 
Equity 
1
2013-03-01 
$3,999,999.00 
$4,999,998.00 
$999,999.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
MARC 
 
COHEN 
DIRECTOR
ONCOPEP, INC.   |  C4 THERAPEUTICS, INC.   |  WRINKL, INC.   |  FREQUENCY THERAPEUTICS, INC.   |  REGENACY PHARMACEUTICALS, INC.   |  ANGIOCRINE BIOSCIENCE, INC.   |  HOCKEY PARENT HOLDINGS, L.P.
BRAD 
 
DANIEL 
DIRECTOR
ANGIOCRINE BIOSCIENCE, INC.
CLAUDE 
GEOFFREY 
DAVIS, PH.D. 
EXECUTIVE OFFICER, DIRECTOR
ANGIOCRINE BIOSCIENCE, INC.
PAUL 
 
FINNEGAN 
EXECUTIVE OFFICER, DIRECTOR
IMPRIMIS PHARMACEUTICALS, INC.   |  MUSTANG INVESTMENT HOLDINGS L.P.   |  MDP HC HOLDINGS, LLC   |  CDW CORP   |  MDP ACM HOLDINGS, LLC   |  MDP SM HOLDINGS, LLC   |  ANGIOCRINE BIOSCIENCE, INC.   |  PROCURATED, INC.   |  PINE STREET HEALTHCARE HOLDINGS, LLC   |  PSHUH, LLC   |  RIVER SEA PSCP ROOFING INVESTOR LLC   |  ALIGNED EXTERIORS GROUP LLC
PAUL 
W 
FINNEGAN 
EXECUTIVE OFFICER, DIRECTOR
ANGIOCRINE BIOSCIENCE, INC.
JOHN 
 
JASKOWIAK 
EXECUTIVE OFFICER
ANGIOCRINE BIOSCIENCE, INC.
JOHN 
R 
JASKOWIAK 
EXECUTIVE OFFICER
ANGIOCRINE BIOSCIENCE, INC.
JEFF 
 
JONAS 
DIRECTOR
ROUNDUP MEDIA, LLC   |  COPEACE PBC   |  GENERATION BIO CO.   |  ANGIOCRINE BIOSCIENCE, INC.   |  RYNE BIOTECHNOLOGY INC.
JOHN 
 
KLACKING, PH.D. 
EXECUTIVE OFFICER, DIRECTOR
ANGIOCRINE BIOSCIENCE, INC.
JOHN 
 
LOMORO 
EXECUTIVE OFFICER
ANGIOCRINE BIOSCIENCE, INC.
JOHN 
T 
LOMORO 
EXECUTIVE OFFICER
ANGIOCRINE BIOSCIENCE, INC.
RICK 
 
MURDOCK 
DIRECTOR
ANGIOCRINE BIOSCIENCE, INC.
DAVID 
 
PARKINSON 
DIRECTOR
NODALITY INC   |  NODALITY, INC.   |  TRUSTWAVE HOLDINGS, INC.   |  ZYNGENIA, INC.   |  ESSA PHARMA INC.   |  REFUGE BIOTECHNOLOGIES, INC.   |  ANGIOCRINE BIOSCIENCE, INC.
JEFFREY 
 
PORT 
DIRECTOR
RF SURGICAL SYSTEMS INC   |  RF SURGICAL SYSTEMS, INC   |  VIEW POINT MEDICAL, INC.   |  TMRW LIFE SCIENCES, INC.   |  ANGIOCRINE BIOSCIENCE, INC.
JEFFREY 
L 
PORT 
DIRECTOR
ANGIOCRINE FUND, LP   |  ANGIOCRINE BIOSCIENCE, INC.
JEFFREY 
L. 
PORT, M.D. 
DIRECTOR
ANGIOCRINE BIOSCIENCE, INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2025-09-05
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2025-08-21 
2021-10-15
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2021-10-01 
2013-03-13
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2013-03-01 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#
NONE
NONE
BOFA SECURITIES, INC.
283942